Pharmacy & Distribution Market Research Reports & Industry Analysis
The U.S. two-class system is divided into prescription and nonprescription, or over-the-counter (OTC), medicines. The advantage is that OTC medicines are conveniently sold in a number of retail outlets so that medicines are available when consumers need them. This emphasis on consumer empowerment directly serves two of the most fundamental demands of any workable health care system -- access and affordability.
In recent years, a few of the world’s pharmacy-only national systems have recognized the growing need for greater access to safe and effective medications. Japan, the Netherlands, Denmark, the United Kingdom, Italy, and Argentina all have been part of this trend toward granting consumers increased access to medicines in more outlets.
The drug distribution system in the U.S. is highly regulated by the U.S. Food and Drug Administration (FDA) to ensure only those medications that have a wide enough safety margin and that can be safely and effectively used without the help of a health care professional are available without a prescription.
The somewhat controversial notion of adding a third class of drugs to the U.S. system has been panned by experts and regulators including the AMA and FDA. They say creating a third transition class of drugs would create another health care-disadvantaged population -- those without easy access to a pharmacist at convenient times.
Pharmacy & Distribution Industry Research & Market Reports
-
Telepharmacy Market Size, Trends, Analysis, and Outlook By Services (Patient Counseling, Remote Dispensing, Drug Therapy Monitoring, Refill Authorization for Prescription Drugs), By Delivery Mode (On-premises, Web-based, Cloud-based), by Region, Country, Segment, and Companies, 2024-2030
... global Telepharmacy market size is poised to register 21.81% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Telepharmacy market across By Services ... Read More
-
Psychedelic Drugs Market Size, Trends, Analysis, and Outlook By Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine, Others), By Application (Treatment Resistant Depression, Opiate Addiction, Post-traumatic Stress Disorder, Narcolepsy, Panic Disorders, Others), By Distribution Channel, Hospital pharmacy, Retail pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), By Distribution Channel, Hospital pharmacy, Retail pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Psychedelic Drugs market size is poised to register 13.57% growth from 2024 to 2030, presenting significant ... Read More
-
Retinal Disorder Treatment Market Size, Trends, Analysis, and Outlook By Type (Macular Degeneration, Diabetic Retinopathy, Others), By Dosage Form (Gels, Eye Solutions, Capsules & Tablets, Eye Drops, Ointments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Retinal Disorder Treatment market size is poised to register 9.7% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Cardiovascular Health Supplements Market Size, Trends, Analysis, and Outlook By Type (Natural Supplements, Synthetic Supplements), By Ingredient (Vitamins & Minerals, Herbs & Botanicals, Omega Fatty Acids, Coenzyme Q10 (CoQ10), Others), By Form (Liquid, Tablet, Capsules, Softgels, Powder, Others), By Distribution Channel (Offline, Online), by Region, Country, Segment, and Companies, 2024-2030
... Softgels, Powder, Others), By Distribution Channel (Offline, Online), by Region, Country, Segment, and Companies, 2024-2030 The global Cardiovascular Health Supplements market size is poised to register 8.71% growth from 2024 to 2030, presenting significant growth ... Read More
-
Schizophrenia Drugs Market Size, Trends, Analysis, and Outlook By Treatment (Oral, Injectable), By Therapeutic Class (Second-Generation Antipsychotics (Risperdal, Invega, Zyprexa, Geodon, Seroquel, Latuda, Aristada, Fanapt, Saphris, Vraylar), Third-Generation Antipsychotics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Schizophrenia Drugs market size is poised to register 5.41% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Intranasal Drug and Vaccine Delivery Market Size, Trends, Analysis, and Outlook By Product (Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler, Others), By Dosage Form (Unit-dose, Multi-dose), By Application (Respiratory disorders, Neurological disorders, Vaccination, Pain Management, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Vaccination, Pain Management, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Intranasal Drug and Vaccine Delivery market size is poised to register 6.46% growth ... Read More
-
Sarcoma Drugs Market Size, Trends, Analysis, and Outlook By Treatment Type (Chemotherapy, Targeted therapy & Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Drugs market size is poised to register 9.14% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Sarcoma Drugs market across By Treatment ... Read More
-
Vulvovaginal Candidiasis Treatment Market Size, Trends, Analysis, and Outlook By Drug Class (Clotrimazole, Nystatin, Fluconazole, Ketoconazole, Terbinafine, Terconazole, Others), By Route of Administration (Oral, Intravenous, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... by Region, Country, Segment, and Companies, 2024-2030 The global Vulvovaginal Candidiasis Treatment market size is poised to register 4.66% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Opioid Use Disorder Market Size, Trends, Analysis, and Outlook By Drug (Buprenorphine, Methadone, Naltrexone), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies & Stores), by Region, Country, Segment, and Companies, 2024-2030
... and Companies, 2024-2030 The global Opioid Use Disorder market size is poised to register 10.42% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Anorexiants Market Size, Trends, Analysis, and Outlook By Route of Administration (Subcutaneous Anorexiants, Oral Anorexiants), By Distribution Channel ( Online Pharmacy, Retail Pharmacy, Hospital Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... market size is poised to register 5.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Anorexiants market across By Route of Administration ... Read More
-
Human Growth Hormone Market Size, Trends, Analysis, and Outlook By Product (Long Acting, Others), By Application (Growth Hormone (GH) Deficiency, Adult GH Deficiency, Pediatric GH Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Gestational Age, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Human Growth Hormone market size is poised to register 11.73% growth from ... Read More
-
Europe Breast Cancer Therapeutics Market Forecast to 2030 - Regional Analysis - by Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies)
... Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), and Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies) The ... Read More
-
Antibiotic Resistance Market Size, Trends, Analysis, and Outlook By Disease (Complicated Urinary Tract Infections, Clostridioides difficile Infection, Acute bacterial skin and skin structure infections, Hospital-acquired bacterial pneumonia, Community-acquired pneumonia, Complicated intra-abdominal infection, Bloodstream infection), By Pathogen, E. coli, K. pneumoniae, P. aeruginosa, S. aureus, A. baumannii, S. pneumoniae, H. influenzae, C. difficile, E. faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Pathogen, E. coli, K. pneumoniae, P. aeruginosa, S. aureus, A. baumannii, S. pneumoniae, H. influenzae, C. difficile, E. faecium), By Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination therapies, Cephalosporins, Others), By Mechanism of Action (Protein Synthesis ... Read More
-
Influenza Medications Market Size, Trends, Analysis, and Outlook By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Distribution Channel ( Hospital Pharmacy, Independent Pharmacy and Drug Store, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... The global Influenza Medications market size is poised to register 5.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Influenza Medications market ... Read More
-
Rare Diseases Treatment Market Size, Trends, Analysis, and Outlook By Therapeutic Area (Cancer, Neurological Conditions, Cardiovascular Conditions, Musculoskeletal Conditions, Hematologic Disorders, Infectious Diseases, Metabolic Diseases, Endocrine Disorders, Others), By Route of Administration (Oral, Injectable, Others), By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... By Drug Type (Biologics, Biosimilar, Others), By Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Rare Diseases Treatment market size is poised to register 12.13% growth ... Read More
-
Anti-Osteoporosis Therapy and Fracture Healing Market Size, Trends, Analysis, and Outlook By Drug (Bi-phosphates, Calcitonin, Estrogen or Hormone Replacement Therapy, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacy, Drug Stores, Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030
... Retail Pharmacy, E-commerce), by Region, Country, Segment, and Companies, 2024-2030 The global Anti-Osteoporosis Therapy and Fracture Healing market size is poised to register 8.71% growth from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Over the Counter Drugs Market Size, Trends, Analysis, and Outlook By Product Type (Cough, Cold and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral and Supplements(VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others), By Formulation Type (Tablets, Liquids, Ointments, Sprays), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... By Formulation Type (Tablets, Liquids, Ointments, Sprays), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Over the Counter Drugs market size is poised to register ... Read More
-
Cannabidiol Market Size, Trends, Analysis, and Outlook By Source (Hemp, Marijuana), By B2B Sales (Pharmaceuticals, Wellness), By B2C Sales Channel (Hospital Pharmacies, Online, Retail Stores), By B2C End User (Medical, Personal Use), By End-User (Medical, Personal Use, Pharmaceuticals, Wellness), by Region, Country, Segment, and Companies, 2024-2030
... Personal Use, Pharmaceuticals, Wellness), by Region, Country, Segment, and Companies, 2024-2030 The global Cannabidiol market size is poised to register 16.01% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
Generic Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Type (Simple Generics, Specialty Generics, Biosimilar), By Application (Central Nervous System Disorders, Respiratory Diseases, Hormones & Related Diseases, Gastrointestinal Diseases, Cardiovascular Diseases, Infectious Diseases, Cancer, Diabetes, Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Product (Small Molecule, Large Molecule), By Route of Administration (Oral, Injectable, Inhalable, Others), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies), by Region, Country, Segment, and Companies, 2024-2030 The global Generic Pharmaceuticals ... Read More
-
E Prescribing Market Size, Trends, Analysis, and Outlook By Product (Solutions, Services), By Delivery Mode (Web/Cloud Based, On Premise), By End-User (Hospital, Office-based Physicians, Pharmacy), By Usage Methods (Handheld, Computer Based Devices), By Substances (Controlled Substances, Non-controlled Substances), By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Substances, Non-controlled Substances), By Specialties (Oncology, Sports Medicine, Neurology, Cardiology, Others), by Region, Country, Segment, and Companies, 2024-2030 The global E Prescribing market size is poised to register 24.77% growth from 2024 to 2030, presenting ... Read More
-
Healthcare Information System Market Size, Trends, Analysis, and Outlook By Application (Hospital Information System, Pharmacy Automation Systems, Laboratory Informatics, Revenue Cycle Management, Medical Imaging Information System), By Deployment (Web-based, On-premises, Cloud-based), By Component (Hardware, Software & Systems, Services), By End-User (Hospitals, Diagnostic Centers, Academic and Research Institutes), by Region, Country, Segment, and Companies, 2024-2030
... & Systems, Services), By End-User (Hospitals, Diagnostic Centers, Academic and Research Institutes), by Region, Country, Segment, and Companies, 2024-2030 The global Healthcare Information System market size is poised to register 12.73% growth from 2024 to ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028
... The point of care diagnostics market is epected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion at a CAGR of 9.4% during the forecast period (2023–2028).The gobal rising burden of ... Read More
-
Retinal Vein Occlusion Treatment Market Size, Trends, Analysis, and Outlook By Disease (Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion), By Type (Anti-vascular Endothelial Growth Factor, Corticosteroid Drugs, Others), By End-user (Hospital & Clinics, Retail Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Retinal Vein Occlusion Treatment market size is poised to register 7.28% growth from 2024 to 2030, presenting significant growth prospects for companies operating in ... Read More
-
Tuberculosis Therapeutics Market Size, Trends, Analysis, and Outlook By Disease (Active TB, Latent TB), By Therapy (First-Line Therapy, Second-Line Therapy), By Route of Administration (Oral, Parenteral, Others), By Dosage Form (Tablets, Capsules, Injection, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), by Region, Country, Segment, and Companies, 2024-2030 The global Tuberculosis Therapeutics market size is poised to register 5.24% growth from 2024 to 2030, presenting significant growth prospects ... Read More
-
Zoonotic Disease Treatment Market Size, Trends, Analysis, and Outlook By Type (Rabies, Tuberculosis, Malaria, Leishmaniasis, Ebola Virus Disease, Others), By Causative Agent (Bacteria, Virus, Nematode, Rodents, Ticks, Others), By Drug Class (Anti-fungal, Anti-bacterial, Antibiotics, Others), By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030
... By Route of Administration (Oral, Topical, Others), By End-user (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Zoonotic Disease ... Read More
Research Assistance
